肿瘤药学
腫瘤藥學
종류약학
ANTI-TUMOR PHARMACY
2014年
5期
389-392
,共4页
万正兰%卓飞霞%谢蓉芝%全任翠%廖怡锋
萬正蘭%卓飛霞%謝蓉芝%全任翠%廖怡鋒
만정란%탁비하%사용지%전임취%료이봉
临床药师%肿瘤科%合理用药%干预
臨床藥師%腫瘤科%閤理用藥%榦預
림상약사%종류과%합리용약%간예
Clinical pharmacist%Oncology department%Rational drug use%Intervention
目的:了解临床药师对肿瘤科不合理用药的干预情况。方法收集2013年7月至2014年4月临床药师对肿瘤科医嘱审核干预记录共96例次,按用法用量、溶媒品种及用量、联合用药、药物选择等进行整理并分析。结果干预较多的类别有溶媒品种不适宜(21.9%)、用法用量超说明书(18.8%)及联合用药不适宜(12.5%)等。其中,对溶媒用量及药物选择不适宜的干预建议采纳率高(100.0%),而联合用药不适宜的干预建议采纳率较低(58.3%)。结论临床药师在医嘱审核中能起到一定的作用,但仍应加强学习,对干预内容应有充分依据和理由,才能提高医师的接受率。
目的:瞭解臨床藥師對腫瘤科不閤理用藥的榦預情況。方法收集2013年7月至2014年4月臨床藥師對腫瘤科醫囑審覈榦預記錄共96例次,按用法用量、溶媒品種及用量、聯閤用藥、藥物選擇等進行整理併分析。結果榦預較多的類彆有溶媒品種不適宜(21.9%)、用法用量超說明書(18.8%)及聯閤用藥不適宜(12.5%)等。其中,對溶媒用量及藥物選擇不適宜的榦預建議採納率高(100.0%),而聯閤用藥不適宜的榦預建議採納率較低(58.3%)。結論臨床藥師在醫囑審覈中能起到一定的作用,但仍應加彊學習,對榦預內容應有充分依據和理由,纔能提高醫師的接受率。
목적:료해림상약사대종류과불합리용약적간예정황。방법수집2013년7월지2014년4월림상약사대종류과의촉심핵간예기록공96례차,안용법용량、용매품충급용량、연합용약、약물선택등진행정리병분석。결과간예교다적유별유용매품충불괄의(21.9%)、용법용량초설명서(18.8%)급연합용약불괄의(12.5%)등。기중,대용매용량급약물선택불괄의적간예건의채납솔고(100.0%),이연합용약불괄의적간예건의채납솔교저(58.3%)。결론림상약사재의촉심핵중능기도일정적작용,단잉응가강학습,대간예내용응유충분의거화이유,재능제고의사적접수솔。
Objective To investigate the intervention of clinical pharmacist on irrational drug use in the oncology. Methods From July 2013 to April 2014, 96 cases of medical record which were intervened by clinical pharmacists in on-cology department were collected and analyzed according to the usage and dosage, menstruum type and quantity, drug com-bination and drug selection of the intervention. Results The major components of intervention included the inappropriate menstruum varieties (21.9%), usage and dosage beyond the drugs instructions (18.8%) and inappropriate drug combination (12.5%), etc. Meanwhile, doctors took advice of clinical pharmacists mostly in solvent volume and drug selection (100.0%), but less in drug combination (58.3%). Conclusion Clinical pharmacists could play a certain role in the audit, but they still should strengthen their professional knowledge. The intervention of clinical pharmacists should be based on sound evidence and reasonable guidelines so as to improve the doctors’acceptance rate.